Stereochemically enriched compositions for delivery of nucleic acids
MA40241AUndetermined Publication Date: 2017-05-03SHIRE HUMAN GENETIC THERAPIES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA40241
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-06-24
- Filing Date
- 2015-06-24
- Publication Date
- 2017-05-03
Abstract
Provided, in part, is a composition comprising one or more chemical entities of formula i, each of which is a compound of formula (i):a pharmaceutically acceptable salt thereof, a solvate thereof, or a solvate of a pharmaceutically acceptable salt thereof, the composition characterized in that greater than a first threshold amount of the total amount of chemical entities of formula i in the composition: are chemical entities of formula i.A, wherein the first threshold amount is 50%; or are chemical entities of formula i.B.1, wherein the first threshold amount is 25%; or are chemical entities of formula i.B.2, wherein the first threshold amount is 25%, wherein the chemical entities of formula i.A, i.B.1, and i.B.2, are described herein, and methods of using such compositions, for example, for the delivery of a polynucleotide
Need to check novelty before this filing date? Find Prior Art